StockData

Femasys Inc (FEMY) income statement

FEMYNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/3037% below fair value
$1.15+0.03 (+2.68%)

Close on Nov 18, 2026Market cap $9.63MP/E –Yield –

Femasys Inc income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
60.9%
Operating margin
-763.9%
Net margin
-511.8%
Return on equity, FY2025
-455.8%

Financial strength

Current ratio
2.14
Debt to equity
–
Debt to assets
–
Cash to current liabilities
37.1%

Valuation

P/E ratio
–
Price to sales
4.19
Price to book
2.39
Dividend yield
–

See a number that looks wrong?